Richard A. Miller - Sep 20, 2022 Form 4 Insider Report for Corvus Pharmaceuticals, Inc. (CRVS)

Role
President and CEO, Director
Signature
/s/ Leiv Lea, as Attorney-in-Fact for Richard A. Miller
Stock symbol
CRVS
Transactions as of
Sep 20, 2022
Transactions value $
$16,253
Form type
4
Date filed
9/20/2022, 06:58 PM
Previous filing
Aug 15, 2022
Next filing
Sep 28, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CRVS Common Stock Purchase $9.96K +12.3K +0.91% $0.81 1.36M Sep 20, 2022 By Trust F1
transaction CRVS Common Stock Purchase $2.21K +2.7K +0.2% $0.82 1.36M Sep 20, 2022 By Trust F1
transaction CRVS Common Stock Purchase $4.08K +5K +0.37% $0.82 1.37M Sep 20, 2022 By Trust F1
holding CRVS Common Stock 35.7K Sep 20, 2022 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These shares are held by Richard A. Miller and Sandra J. Horning, Trustees of the Miller-Horning Family Trust u/a/d January 25, 1985 (the "Miller-Horning Trust"). Dr. Miller has shared voting, investment and dispositive power over the shares held by the Miller Horning Trust.